Taking daily low-dose aspirin does not seem to reduce the risk of dementia, cognitive decline, or Alzheimer’s disease,…
Articles by Marisa Horak, MS
Axsome Therapeutics is planning to complete its ADVANCE-1 clinical trial, evaluating AXS-05 as a treatment for agitation in Alzheimer’s…
Biogen is acquiring from Pfizer investigational therapy PF-05251749, a small molecule being developed to treat sundowning in …
Longer sequence repeats in or near two genes may be linked to a higher risk of late-onset Alzheimer’s disease,…
A newly opened Phase 2 clinical trial will test the sensitivity of new imaging tool for plaque buildup in the…
A diet that is high in salt can cause dementia in mice by promoting a buildup of plaques of the…
NeuroEM Therapeutics‘s MemorEMTM — a head-worn device that uses electromagnetic waves — has shown promising results in a preliminary…
An investigational Alzheimer’s treatment called bryostatin-1 failed to meet its primary goal — lesser evidence of dementia in people with…
The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol…
A gene associated with a rare balance disorder also may be involved in susceptibility to Alzheimer’s disease, a new study…